bioRxivImmunology
Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
T. Noy-Porat, E. Makdasi, R. Alcalay, A. Mechaly, Y. Levy, A. Bercovich-Kinori, A. Zauberman, H. Tamir, Y. Yahalom-Ronen, M. Israeli, E. Epstein, H. Achdout, S. Melamed, T. Chitlaru, S. Weiss, E. Peretz, O. Rosen, N. Paran, S. Yitzhaki, S. C. Shapira, T. Israely, O. Mazor, R. Rosenfeld
Abstract
The novel highly transmissible human coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Thus far, there is no approved therapeutic drug, specifically targeting this emerging virus. Here we report the isolation and characterization of a panel of human neutralizing monoclonal antibodies targeting the SARS-CoV-2 receptor binding domain (RBD). These antibodies were selected from a phage display library constructed using peripheral circulatory lymphocytes collected from patients at the acute phase of the disease. These neutralizing antibodies are shown to recognize distinct epitopes on the viral spike RBD, therefore they represent a promising basis for the design of efficient combined post-exposure therapy for SARS-CoV-2 infection.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
T. Noy-Porat, A. Mechaly, … R. Rosenfeld·bioRxiv·Feb 2, 2021
- Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models
W. Li, A. Drelich, … D. S. Dimitrov·bioRxiv·May 13, 2020
- Isolation of and Characterization of Neutralizing Antibodies to Covid-19 from a Large Human Naïve scFv Phage Display Library
A. Q. Yuan·bioRxiv·May 19, 2020
- Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library
B. N. Bell, A. E. Powell, … P. S. Kim·bioRxiv·Jan 7, 2021
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
F. Bertoglio, D. Meier, … M. Hust·bioRxiv·Jun 5, 2020
- Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
L. Liu, P. Wang, … D. D. Ho·NaturePeer-reviewed·Jul 22, 2020